Pulse intracerebroventricular injection of eledoisin, but not of substance P, markedly increases plasma vasopressin levels in the rat. Intracerebroventricular pretreatment with sarcosine1, alanine8-angiotensin II, 1 microgram/rat, completely suppresses the effect of eledoisin, suggesting that it is mediated by angiotensin release and angiotensin II receptor activation. The vasopressin releasing effect of eledoisin is neither due to peripheral haemodynamic alterations, nor to activation of the peripheral renin-angiotensin system. It is apparently related to central angiotensin release in a specific neuronal pathway subserving vasopressin release. This effect is not secondary to inhibition by tachykinins of the brain mechanisms for angiotensi...
The effect on water intake, urine flow and vasopressin release of intracranial injections of substan...
Angiotensin II (ANG II) causes a systemic pressor effect when injected into the cerebral ventricles....
The present study investigated the sensitivity of 12 forebrain and midbrain structures to the antidi...
Pulse intracerebroventricular injection of eledoisin, but not of substance P, markedly increases pla...
The intracerebroventricular injection of eledoisin (ELE), or of other tachykinins with potent agonis...
The intracerebroventricular injection of eledoisin (ELE), or of other tachykinins with potent agonis...
The intracerebroventricular injection of eledoisin (ELE), or of other tachykinins with potent agonis...
The present study investigated the effect on vasopressin release of the intracerebroventricular inje...
Angiotensin II (Ang II), peripherally or centrally administered, increases plasma vasopressin concen...
This study investigated the sensitivity of spontaneously hypertensive rats (SHR) and of Wistar Kyoto...
This study investigated the sensitivity of spontaneously hypertensive rats (SHR) and of Wistar Kyoto...
Various dipsogenic stimuli, including peripheral and central administration of angiotensin II, have ...
Pharmacological enhancement of 5-hydroxytryptamine (5-HT) transmission increases plasma vasopressin ...
The effect on water intake, urine flow and vasopressin release of intracranial injections of substan...
The effect on water intake, urine flow and vasopressin release of intracranial injections of substan...
The effect on water intake, urine flow and vasopressin release of intracranial injections of substan...
Angiotensin II (ANG II) causes a systemic pressor effect when injected into the cerebral ventricles....
The present study investigated the sensitivity of 12 forebrain and midbrain structures to the antidi...
Pulse intracerebroventricular injection of eledoisin, but not of substance P, markedly increases pla...
The intracerebroventricular injection of eledoisin (ELE), or of other tachykinins with potent agonis...
The intracerebroventricular injection of eledoisin (ELE), or of other tachykinins with potent agonis...
The intracerebroventricular injection of eledoisin (ELE), or of other tachykinins with potent agonis...
The present study investigated the effect on vasopressin release of the intracerebroventricular inje...
Angiotensin II (Ang II), peripherally or centrally administered, increases plasma vasopressin concen...
This study investigated the sensitivity of spontaneously hypertensive rats (SHR) and of Wistar Kyoto...
This study investigated the sensitivity of spontaneously hypertensive rats (SHR) and of Wistar Kyoto...
Various dipsogenic stimuli, including peripheral and central administration of angiotensin II, have ...
Pharmacological enhancement of 5-hydroxytryptamine (5-HT) transmission increases plasma vasopressin ...
The effect on water intake, urine flow and vasopressin release of intracranial injections of substan...
The effect on water intake, urine flow and vasopressin release of intracranial injections of substan...
The effect on water intake, urine flow and vasopressin release of intracranial injections of substan...
Angiotensin II (ANG II) causes a systemic pressor effect when injected into the cerebral ventricles....
The present study investigated the sensitivity of 12 forebrain and midbrain structures to the antidi...